About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | HIV/AIDS Clinical Trials | 1,627 Studies Recruiting

Clinical TrialsHIV/AIDS

HIV/AIDS Clinical Trials

Browse 1,627 clinical trials for hiv/aids. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 241-260 of 1,627 trials

Active not recruitingImmunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell LymphocytopeniaBackground: Diseases related to human papillomavirus (HPV) include warts, lesions, and cancers. ICL is idiopathic CD4 T cell lymphocytopenia.NCT03519464·Bethesda, Maryland CompletedEvaluation Study of RDTs Detecting Antibodies Against HCVThe study aims to evaluate 13 different HCV RDTs (10 on-market, 3 under development) for their diagnostic performance and operational characteristics in archived EDTA plasma…NCT04033887·Antwerp and 2 others

Related Searches

aidstrials human immunodeficiencytrials

Data from ClinicalTrials.govTerms

CompletedCognitive Training for the Remediation of Functional Brain Health in HIVCognitive deficits in HIV reflect degraded brain network functioning that may be amenable to remediation through cognitive training.NCT02571504·Montreal, Quebec

CompletedA Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)The purpose of this study is to assess the efficacy and safety of ABT-493/ABT-530 in adults with chronic hepatitis C virus genotype 1-6 infection and human immunodeficiency…NCT02738138

CompletedHepatitis B and HIV Co-Infection in Patients in UgandaThis study will determine the amount of liver scarring (fibrosis) or liver damage in people infected with 1) hepatitis B virus (HBV, a virus that can infect the liver); 2) HIV…NCT00782158·Kampala and 1 other

CompletedA Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted ConditionsThe purpose of this study is to evaluate the single-dose pharmacokinetics and bioequivalence of darunavir 800 mg when administered as a fixed dose combination relative to 2 x 400…NCT01619527·Merksem

UnknownImmediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous MeningitisThe optimal time to initiate antiretroviral therapy (ART) in HIV-associated tuberculous meningitis (TBM) unknown.NCT00433719·Ho Chi Minh City and 1 other

CompletedA Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment FailuresBackground: * Chronic hepatitis C (CHC) is a major health problem that particularly affects individuals with human immunodeficiency virus (HIV) infection, and can lead to…NCT01185028·Washington D.C., District of Columbia and 3 others

CompletedGSK3739937 First-Time-In-Human (FTIH) Study in Healthy VolunteersThis study is a Phase 1, double-blind (sponsor-unblinded), randomized, placebo-controlled, single- and repeat-dose escalation study including a weekly oral dose (MAD) cohort and a…NCT04493684·Baltimore, Maryland

CompletedSafety and Acceptability of a Vaginal MicrobicideThe purpose of this study is to determine the safety and acceptability of a vaginal microbicide in HIV uninfected sexually active women.NCT00111943·Birmingham, Alabama and 2 others

CompletedPhase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected PatientsTo determine how fast ribavirin reaches the bloodstream, what concentration of ribavirin is reached in blood and how long it remains in the blood (pharmacokinetics) when given by…NCT00000733·New Orleans, Louisiana and 1 other

CompletedEnhanced Prevention in Couples: Feasibility Study #2The purpose of this study is to gather information needed to develop a large prevention trial to decrease risk for Human immunodeficiency virus (HIV) transmission among…NCT02027441·Mafeteng and 1 other

Not yet recruitingImpact of Migration History and Social Conditions on the Immuno-virological Control of HIV in Migrants in FranceMigrants living with HIV - whether the infection was diagnosed in their country of origin or in France- frequently experience vulnerabilities related to their migration…NCT07691424·Clermont-Ferrand, France

Not yet recruitingDisease Evolution and Risk Factors of AIDS-related Prevalent CancersThis study aims to investigate the disease progression trends and risk factors of common AIDS-related tumors, including Kaposi sarcoma, lymphoma, lung cancer, and et al., among…NCT07696169

CompletedMulti-level Determinants of Starting ART Late: Aim 2The availability of HIV care and treatment programs is increasing in sub-Saharan Africa.NCT01997346·Fichē and 3 others

UnknownMulticenter Performance Study of QuadQuik Invitro Diagnostic DeviceTo Demonstrate Clinical Performance of the TriQuik Invitro Diagnostic DeviceNCT05692505·San Diego, California

CompletedA Study to Investigate the Safety and Pharmacokinetics of a Single Dose of VH3810109 (Also Known as GSK3810109), Administered Either Subcutaneously (SC) With rHuPH20 or Intravenously (IV), in Healthy Adult ParticipantsAn open-label, two part study to assess the safety, tolerability, and PK of VH3810109 in healthy adult participants.NCT05291520·Austin, Texas

CompletedHIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive AdultsThis is a Phase IIIB, 48 Week, multicentre, randomized, open-label, parallel group study comparing the safety and efficacy of fosamprenavir plus ritonavir 1400mg/100mg once-daily…NCT00450580·Antwerp and 68 others

CompletedTechMPower: Advancing HIV/SUD Care and Service Delivery for People in Re-entryThe goal of this clinical study in one NY county is to pilot and refine implementation strategies aimed at improving delivery and uptake of evidence-based practices (EBPs) for HIV…NCT07088770·Kingston, New York

TerminatedPegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)This is an uncontrolled, open-label, Phase III trial of peginterferon alfa-2a (Pegasys) in participants coinfected with human immunodeficiency virus (HIV) and hepatitis C virus…NCT02762383·Brussels and 9 others

PreviousPage 13 of 82Next